Abstract:BACKGROUND:Traditional Chinese Medicine (TCM) possesses several advantages for treating patients with hepatocellular carcinoma (HCC). The theory of 'Jianpi Huayu Therapy' rooted from 'Jin Kui Yao Lue' is one of the most important therapies in this respect. This study was conducted to investigate the clinical effect and safety of hepatectomy combining with 'Jianpi Huayu Therapy' in the treatment of HCC.MATERIALS AND METHODS:One hundred and twenty patients with HCC were randomized allocated into hepatectomy combined with 'Jianpi Huayu Therapy' group (treatment group, n=60) and hepatectomy alone group (control group, n=60). Disease-free survival (DFS) and overall survival (OS) were the primary end-points. Liver function at the end of one week after surgery, complications, average days of hospitalization as well as performance status (PS) at the end of one month post operation were also compared.RESULTS:No significant differences existed between two groups on baseline analysis (p>0.05). No treatment related mortality occurred in either group. Post-operative complications were detected among 14 patients (23.3%) in the treatment group, and 12 (20.0%) in the control group (p=0.658). Alanine aminotransferase (ALT) at the end of one week after operation was lower in the treatment than control groups (p=0.042). No significant differences in other indexes of liver function were discovered between two groups. Average days of hospitalization reduced by 0.9 day in treatment group than in control (p=0.034). During follow-up, 104 patients (86.6%) developed recurrence. The rates of 1-, 3-, and 5-year DFS and median DFS for all patients were 77.4%, 26.3%, 9.0% and 25.6 months (range, 6.0~68.0), respectively (78.2%, 29.2%, 14.3% and 28.7 months for the 48 patients in the treatment group and 75.0%, 23.3%, 6.4%, and 22.6 months for the 56 patients in the control group (p=0.045)). 101 patients had died at the time of censor, with 1-, 3-, and 5-year overall survival rates and median survival for all patients of 97.5%, 76.4%, 40.5% and 51.2 months (range, 10.0~72.0), respectively (98.3%, 78.0%, 43.6% and 52.6 months, for treatment and 96.7%, 74.7%, 37.4%, and 49.8 months, for controls, respectively (p=0.048)).CONCLUSIONS:Hepatectomy combined with 'Jianpi Huayu therapy' was effective in the treatment of HCC, and reduced post-operative recurrence and metastasis and improved DFS and OS of HCC patients.

The therapeutic effects of Qing Re Hua Ji(QRHJ) decoction combined with HAI/TACE treating advanced pancreatic cancer: A randomize, control clinical study

A Clinical Trial on the Effect of Qingyi Huaji Herbal Decoction Combined with Transcatheter Arterial Chemotherapy and Radiotherapy for Inoperable Pancreatic Cancer

Qingrehuashi Herbal Formula combined with high intensity focused ultrasound for treating advanced pancreatic cancer

The Clinical Effect of Qinggan-Jiedu Decoction Adjuvant Microwave Coagulation Therapy on the Patients of Liver Cancer

Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer

[A Retrospective Study of Chinese Herbal Medicine Combined with Systemic Chemotherapy And/or Regional Arterial Perfusion for Pancreatic Cancer with Liver Metastases].

Survival Analysis on 64 Cases of Advanced Pancreatic Cancer Treated by Integrated Western and Traditional Chinese Medicine Mainly with Qingyi Huaji Formula

Effects of Qingyi Huaji Decoction on Serum Levels of Interleukin-6, Interleukin-8 and Tumor Necrosis Factor-Α in Nude Mice Bearing Pancreatic Tumors

Therapeutic Efficacy Evaluation and Underlying Mechanisms Prediction of Jianpi Liqi Decoction for Hepatocellular Carcinoma

Prognostic analysis of 190 elderly patients with pancreatic cancer treated by integrated traditional Chinese and West-ern medicine therapy

Prognostic analysis of 190 elderly patients with pancreatic cancer treated by integrated traditional Chinese and Western medicine therapy

Clinieal studies on the therapeutic effeets of combined therapy with TACE and Qi-boosting toxin-resolving granule on hepatic carcinoma

The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.

Clinical Curative Effect of Yiqihuoxue Decoction Combined with Chemotherapy on the Patients with Advanced Bladder Cancer

Effect Observation of Huangqi Injection Combined with Chemotherapy on Quality of Life of Postoperation Patients with Advanced Stage Colorectal Carcinoma

Curative Effect of Jianpi Yiqi Jiedu Decoction Combined with Chemotherapy on the Patients with Advanced Colorectal Cancer

Clinical Study of Hepatectomy Combined with Jianpi Huayu Therapy for Hepatocellular Carcinoma

Clinical observation on anti-cancer decoction combined with TACE for HCC in Qi-deficiency and blood stasis

Effect of Qingyi Huaji Decoction Combined with Gemcitabine on Apoptosis and Expression of Bcl-2 Protein of Pancreastic Cancer SW1990 in Vivo

Anti-tumor Effect of the Extract from Qingyihuaji Formula on Pancreatic Cancer by Down-Regulating Notch-4 and Jagged-1.

Clinical Observation of 65 Cases with Hepatocellular Carcinoma Treated by Huqisan and Transeatheter Arterial Chemoembolization